IBDEI0CJ ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5602,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5602,1,3,0)
 ;;=3^394.0
 ;;^UTILITY(U,$J,358.3,5602,1,4,0)
 ;;=4^MITRAL STENOSIS
 ;;^UTILITY(U,$J,358.3,5602,2)
 ;;=^78404
 ;;^UTILITY(U,$J,358.3,5603,0)
 ;;=424.0^^28^370^18
 ;;^UTILITY(U,$J,358.3,5603,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5603,1,3,0)
 ;;=3^424.0
 ;;^UTILITY(U,$J,358.3,5603,1,4,0)
 ;;=4^MITRAL VALVE PROLAPSE
 ;;^UTILITY(U,$J,358.3,5603,2)
 ;;=^78367
 ;;^UTILITY(U,$J,358.3,5604,0)
 ;;=458.0^^28^370^19
 ;;^UTILITY(U,$J,358.3,5604,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5604,1,3,0)
 ;;=3^458.0
 ;;^UTILITY(U,$J,358.3,5604,1,4,0)
 ;;=4^ORTHOSTATIC HYPOTENSION
 ;;^UTILITY(U,$J,358.3,5604,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,5605,0)
 ;;=785.1^^28^370^20
 ;;^UTILITY(U,$J,358.3,5605,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5605,1,3,0)
 ;;=3^785.1
 ;;^UTILITY(U,$J,358.3,5605,1,4,0)
 ;;=4^PALPITATIONS
 ;;^UTILITY(U,$J,358.3,5605,2)
 ;;=^89281
 ;;^UTILITY(U,$J,358.3,5606,0)
 ;;=423.8^^28^370^21
 ;;^UTILITY(U,$J,358.3,5606,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5606,1,3,0)
 ;;=3^423.8
 ;;^UTILITY(U,$J,358.3,5606,1,4,0)
 ;;=4^PERICARDIAL DISEASE NEC
 ;;^UTILITY(U,$J,358.3,5606,2)
 ;;=^269713
 ;;^UTILITY(U,$J,358.3,5607,0)
 ;;=443.89^^28^370^22
 ;;^UTILITY(U,$J,358.3,5607,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5607,1,3,0)
 ;;=3^443.89
 ;;^UTILITY(U,$J,358.3,5607,1,4,0)
 ;;=4^PERIPH VASCULAR DIS NEC
 ;;^UTILITY(U,$J,358.3,5607,2)
 ;;=^87788
 ;;^UTILITY(U,$J,358.3,5608,0)
 ;;=427.81^^28^370^23
 ;;^UTILITY(U,$J,358.3,5608,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5608,1,3,0)
 ;;=3^427.81
 ;;^UTILITY(U,$J,358.3,5608,1,4,0)
 ;;=4^SICK SINUS SYNDROME
 ;;^UTILITY(U,$J,358.3,5608,2)
 ;;=^110852
 ;;^UTILITY(U,$J,358.3,5609,0)
 ;;=780.2^^28^370^24
 ;;^UTILITY(U,$J,358.3,5609,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5609,1,3,0)
 ;;=3^780.2
 ;;^UTILITY(U,$J,358.3,5609,1,4,0)
 ;;=4^SYNCOPE
 ;;^UTILITY(U,$J,358.3,5609,2)
 ;;=^116707
 ;;^UTILITY(U,$J,358.3,5610,0)
 ;;=785.0^^28^370^25
 ;;^UTILITY(U,$J,358.3,5610,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5610,1,3,0)
 ;;=3^785.0
 ;;^UTILITY(U,$J,358.3,5610,1,4,0)
 ;;=4^TACHYCARDIA NOS
 ;;^UTILITY(U,$J,358.3,5610,2)
 ;;=^117041
 ;;^UTILITY(U,$J,358.3,5611,0)
 ;;=424.90^^28^370^26
 ;;^UTILITY(U,$J,358.3,5611,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5611,1,3,0)
 ;;=3^424.90
 ;;^UTILITY(U,$J,358.3,5611,1,4,0)
 ;;=4^VAVULAR HEART DISEASE
 ;;^UTILITY(U,$J,358.3,5611,2)
 ;;=^40327
 ;;^UTILITY(U,$J,358.3,5612,0)
 ;;=459.81^^28^370^27
 ;;^UTILITY(U,$J,358.3,5612,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5612,1,3,0)
 ;;=3^459.81
 ;;^UTILITY(U,$J,358.3,5612,1,4,0)
 ;;=4^VENOUS INSUFFICIENCY NOS
 ;;^UTILITY(U,$J,358.3,5612,2)
 ;;=^125826
 ;;^UTILITY(U,$J,358.3,5613,0)
 ;;=453.6^^28^370^28
 ;;^UTILITY(U,$J,358.3,5613,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5613,1,3,0)
 ;;=3^453.6
 ;;^UTILITY(U,$J,358.3,5613,1,4,0)
 ;;=4^VENOUS THROMBOSIS,LOWER EXTREMITY
 ;;^UTILITY(U,$J,358.3,5613,2)
 ;;=^338243
 ;;^UTILITY(U,$J,358.3,5614,0)
 ;;=453.83^^28^370^29
 ;;^UTILITY(U,$J,358.3,5614,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5614,1,3,0)
 ;;=3^453.83
 ;;^UTILITY(U,$J,358.3,5614,1,4,0)
 ;;=4^VENOUS THROMBOSIS,UPPER EXTREMITY
 ;;^UTILITY(U,$J,358.3,5614,2)
 ;;=^338254
 ;;^UTILITY(U,$J,358.3,5615,0)
 ;;=280.9^^28^371^3
 ;;^UTILITY(U,$J,358.3,5615,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5615,1,3,0)
 ;;=3^280.9
 ;;^UTILITY(U,$J,358.3,5615,1,4,0)
 ;;=4^ANEMIA,IRON DEFIC
 ;;^UTILITY(U,$J,358.3,5615,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,5616,0)
 ;;=285.21^^28^371^1
 ;;
 ;;$END ROU IBDEI0CJ
